Skip to content

Effects of probiotics on in-hospital mortality in patients with acute myocardial infarction: a randomized, open-label, superiority clinical trial

Effects of probiotics on in-hospital mortality in patients with acute myocardial infarction:a randomized, open-label, superiority clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038797
Enrollment
Unknown
Registered
2020-10-02
Start date
2020-10-01
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

control group:blank control

Sponsors

The first Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. aged >=18 years old; 2. For both men and women; 3. Patients diagnosed as acute myocardial infarction; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Pregnant and nursing women; 2) Patients using microecological preparations in recent one month or patients with diarrhea at admission requiring the use of probiotics 3) Patients with intolerance to microecological preparations, patients with immunodeficiency and long-term use of immunosuppressive agents; 4) Only stable or unstable angina pectoris did not develop to myocardial infarction; 5) Patients who are participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
in-hospital mortality;

Secondary

MeasureTime frame
Major adverse cardiovascular events (MACE);Ventricular systolic function;

Countries

China

Contacts

Public ContactYequn Chen

the First Affiliated Hospital of Shantou University Medical College

gdcycyq@163.com+86 0754 88905620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026